UK Plans Genome Sequencing for All Newborns Within Decade

The UK is advancing its genomic medicine capabilities with plans to offer whole genome sequencing to all newborns within the next ten years, aiming to detect hundreds of diseases early and personalize healthcare. This initiative builds on the Generation Study under the Newborn Genomes Programme, which is currently sequencing 100,000 newborns to identify actionable rare genetic conditions. The government’s 10-year health plan also includes integrating genomic data into cardiovascular disease prevention and expanding genomic insights through the Our Future Health research programme. In parallel, the Functional Genomics Screening Laboratory at the University of Cambridge, supported by AstraZeneca and the MRC, provides researchers access to automated CRISPR screening to develop new therapies for chronic diseases. Similarly, in the United States, Gundersen Health System in La Crosse, Wisconsin, is joining the Badger Baby Network to bring genomic testing to newborns locally, facilitating early diagnosis and treatment of genetic conditions. These efforts collectively demonstrate a global shift towards predictive and personalized medicine through genomic technologies.